Actively Recruiting
Subsartorial Nerve Block and Femoral Nerve Block in Total Knee Arthroplasty
Led by Luzerner Kantonsspital · Updated on 2024-03-12
144
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to compare two different types of nerve blocks in patients undergoing surgery for primary Total Knee Arthroplasty. The main question aim to answer is: \- is there a benefit in functional muscle power output of the leg? Participants will be randomized into either the intervention group or the control group and: * receive Subsartorial Saphenous Nerve Block (SSNB) + IPACK in intervention group (group 1) * receive Femoral Nerve Block (FNB) + IPACK in control group (group 2) Researchers will compare the 2 groups to see if there are differences in : * functional muscle power output of the leg? * muscle function, mobility, clinical and radiological results, ROM, pain control (NRS), opioid consumption, length of hospital stay, patient satisfaction, mobility, reduction of costs?
CONDITIONS
Official Title
Subsartorial Nerve Block and Femoral Nerve Block in Total Knee Arthroplasty
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age greater than 18 years
- Undergoing primary total knee arthroplasty
- Body mass index (BMI) of 35 kg/m2 or less
- Able to provide informed consent documented by signature
- No contraindications for the planned intervention based on clinical history
You will not qualify if you...
- Age less than 18 years
- Revision total knee arthroplasty
- Body mass index (BMI) greater than 35 kg/m2
- No contact information available
- Inability or contraindications to undergo total knee arthroplasty or nerve block procedures
- Presence of clinically significant other diseases
- Pregnancy
- Inability to follow study procedures or follow-up (due to language problems, psychological disorders, dementia, living abroad, etc.)
- Withdrawal from the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Luzerner Kantonsspital
Lucerne, Switzerland, 6000
Actively Recruiting
Research Team
J
Judith Bering, Dr. med.
CONTACT
L
Laura V Buchmann, Dr. med.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here